Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular Carcinoma
Open Access
- 1 February 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (2), 409-416
- https://doi.org/10.1158/1055-9965.epi-08-0575
Abstract
Objective: Inhibitor of growth 4 (ING4) is a candidate tumor suppressor that plays an important role in tumor growth and angiogenesis. Here, we examined the expression of ING4 in hepatocellular carcinoma (HCC) tissues and analyzed its correlation with the progression of HCC. Methods: Specimens from 136 HCC patients were determined immunohistochemically for ING4 expression. The correlation of ING4 levels with clinicopathologic variables, prognosis, and metastatic potential was analyzed. Among the 136 cases, 36 paired HCC and paracarcinomatous liver tissue specimens were analyzed for ING4 expression levels by real-time quantitative reverse transcription-PCR and Western blotting. MVD was determined by CD34 immunostaining to test whether it correlated with ING4 protein expression level. Results: The ING4 mRNA and protein levels were significantly lower in HCC than paracarcinomatous liver tissue from both real-time quantitative reverse transcription-PCR and Western blotting (P = 0.039 and 0.012, respectively). Importantly, the ING4 protein level correlated with the Edmondson-Steiner grade (P = 0.035), vein invasion (P = 0.015), and microvessel density (P = 0.005). Survival and metastasis analysis indicated that HCC patients with lower ING4 expression had poorer overall survival and disease-free survival than those with high expression (P = 0.0001 and 0.0065; respectively). Multivariable Cox regression analysis revealed that the ING4 expression level was an independent factor for prognosis (hazard risk, 9.63; P = 0.001). Conclusions: ING4 expression is down-regulated in HCC tissues. ING4 expression level correlates with prognosis and metastatic potential, which suggests that ING4 is a candidate prognostic marker of HCC. (Cancer Epidemiol Biomarkers Prev 2009;18(2):409–16)Keywords
This publication has 28 references indexed in Scilit:
- Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesisCancer Letters, 2008
- The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 α (HIF-1α) activity: involvement in myeloma-induced angiogenesisBlood, 2007
- Inhibitor of Growth 4 Suppresses Cell Spreading and Cell Migration by Interacting with a Novel Binding Partner, Liprin α1Cancer Research, 2007
- The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinasesInternational Journal of Cancer, 2006
- Increased Expression of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein 2 Correlated with Poor Prognosis of Hepatocellular CarcinomaClinical Cancer Research, 2006
- Novel Concepts in Hepatocellular Carcinoma: From Molecular Research to Clinical PracticeJournal of Clinical Gastroenterology, 2006
- A long‐term follow‐up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomyCancer, 2005
- ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA‐damage agents in HepG2 cellsFEBS Letters, 2004
- The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesisNature, 2004
- Characterization of RhoC Expression in Benign and Malignant Breast DiseaseThe American Journal of Pathology, 2002